Indicative takeover proposal and euphoric market response
The Asia-Pacific mergers and acquisitions landscape recorded a major institutional transaction on Monday as TAL Dai-ichi Life Australia Pty submitted a formal indicative offer to acquire complete control of Challenger Limited. The Japanese insurer is seeking to purchase all outstanding shares it does not currently own at a price of A$11.80 apiece, commanding an overall equity valuation of A$7.94 billion and offering a lucrative 19.8 percent premium to existing public shareholders.
Equities markets reacted with immediate enthusiasm: Challenger's stock surged more than 15 percent to trade at A$11.33, touching its strongest valuation level since October 2018.

















